Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis Inc. has demonstrated significant financial growth, with its India business revenues surging to $12 million in Q2 from $3 million in Q1 2025, indicating a robust rebound and solid demand. The company anticipates continued expansion in its India segment through new contracts in the upcoming quarters, suggesting a positive trajectory for future revenue streams. With an attractive current valuation underscored by a net present value (NPV) analysis that reflects considerable potential for share price appreciation, Aemetis is positioned favorably in the renewable fuels and biochemicals sector.

Bears say

Aemetis Inc. reported weaker than expected fiscal Q2 2025 results, with revenue declining and an earnings per share (EPS) of $(0.41), which fell short of both internal estimates and consensus expectations. The company's revenue estimates for 2025 have been revised down from $280 million to $270 million, indicating ongoing challenges in achieving projected financial performance. Additionally, the adjusted EPS forecast reflects a slight improvement but remains negative at $(1.37), signaling potential difficulties in returning to profitability within the near term.

Aemetis (AMTX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Nov 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.